Skip to content

Transcutaneous electrical acupoint stimulation vs. sham stimulation combined with dexamethasone vs. tropisetron for preventing postoperative nausea and vomiting after cesarean delivery: protocol for a randomized controlled factorial Trial

Transcutaneous electrical acupoint stimulation vs. sham stimulation combined with dexamethasone vs. tropisetron for preventing postoperative nausea and vomiting after cesarean delivery: protocol for a randomized controlled factorial Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001044
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-05-30
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

sham stimulation with dexamethasone:Participants received sham stimulation and intravenous dexamethasone immediately after fetal delivery
sham stimulation with tropisetron:Participants received sham stimulation and intravenous tropisetron immediately after fetal delivery
TEAS with tropisetron:Participants received TEAS and intravenous tropisetron immediately after fetal delivery
TEAS with dexamethasone:Participants received TEAS and intravenous dexamethasone immediately after fetal delivery

Sponsors

Ordos Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA physical status I-II; Patients with full term, singleton pregnancy; Scheduled for cesarean delivery; Informed consent provided by patients and their families.

Exclusion criteria

Exclusion criteria: Diabetes mellitus; History of carpal tunnel syndrome; Suffering from nausea or vomiting within 24 h before cesarean delivery; Current use of acupuncture therapies; Receive antiemetic or glucocorticoid within 24 h before surgery; Pacemaker or defibrillator device implantation.

Design outcomes

Primary

MeasureTime frame
the occurrence of PONV within the first 48 hours after surgery;

Secondary

MeasureTime frame
pain scores during movement;the use of rescue analgesics;QoR-15 scores;nausea;retching;pain scores at rest;hospital stay duration;opioid consumption;the severity of PONV;patient satisfaction;vomiting;the use of rescue antiemetics;

Countries

China

Contacts

Public ContactRuizhen Li

Ordos Central Hospital

ruizhen20201220@163.com156 6188 8878

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026